Awards as PI
| Funding | ||
|---|---|---|
| Tools and Technologies I | The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells | $1,141,124 |
| Early Translational I | Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation | $6,292,290 |
| Shared Labs | Center for hESC Research | $3,828,751 |
| Transplantation Immunology | Thymus based tolerance to stem cell therapies | $1,269,844 |
Total: $12,532,009.00 |
Awards as Co-PI
| Early Translational III | Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
